AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

TRLV · NYSE · Drug Manufacturers - Specialty & Generic

Trulieve Cannabis (TRLV)

Vertically integrated medical-cannabis cultivator, manufacturer, and dispensary operator.

$12.71

vs last close+0.24 (+1.92%)

In millions of USD, except per-share figures

In millions	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	302	288	293	287	271
Cost of revenue	119	118	118	117	109
Gross profit	183	170	175	170	162
	131	128	156	135	533
Selling, general & administrative	101	99	126	105	102
Other expenses	29	29	29	30	431
Operating income	52	41	19	35	−371
	−13	−12	−16	−10	−13
Interest income	4	4	3	3	3
Interest expense	16	16	15	13	13
Other non-operating income	−3	−4	2	−3	0
Income before tax	39	29	3	25	−383
Income tax expense	55	53	48	22	22
Net income from continuing operations	−16	−24	−45	3	−405
Discontinued operations	0	−5	1	−1	−1
Other adjustments	0	0	0	0	0
Net income	−14	−27	−43	2	−406
EPS, basic	−$0.07	−$0.14	−$0.22	$0.01	−$2.10
EPS, diluted	−$0.07	−$0.14	−$0.22	$0.01	−$2.10
Weighted average shares, basic	191	191	192	193	193
Weighted average shares, diluted	191	191	192	198	193
EBITDA	98	89	61	82	−371
Depreciation & amortization	43	43	44	44	0
EBIT	55	45	18	39	−371